Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO8977 | Notholaena aschenborniana | Species | Pteridaceae | Eukaryota | UNPD* | |||
NPO6828 | Purpura aperta | Species | Muricidae | Eukaryota | UNPD* | |||
NPO2455 | Thermopsis mollis | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO4382 | Elmerrillia papuana | NA | NA | NA | UNPD* | |||
NPO1490 | Goldfussia yunnanensis | NA | NA | NA | UNPD* | |||
NPO27517 | Crinum latifolium | Species | Amaryllidaceae | Eukaryota | UNPD* | |||
NPO5635 | Bauhinia purpurea | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO9881 | Petrosia hebes | Species | Petrosiidae | Eukaryota | UNPD* | |||
NPO4628 | Aloe deltoideodonta | Species | Asphodelaceae | Eukaryota | UNPD* | |||
NPO9608 | Lepraria citrina | Species | Stereocaulaceae | Eukaryota | UNPD* | |||
NPO809 | Leitneria floridana | Species | Simaroubaceae | Eukaryota | UNPD* | |||
NPO8807 | Laurentia longiflora | NA | NA | NA | UNPD* | |||
NPO3357 | Alnus cordata | Species | Betulaceae | Eukaryota | UNPD* | |||
NPO25475 | Syphonota geographica | Species | Aplysiidae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT168 | Cell Line | P388 | Mus musculus | GI50 | = | 23.2 | ug/ml | 16562827 |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 3.8 | ug/ml | 16562827 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 3.1 | ug/ml | 16562827 |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | = | 3.2 | ug/ml | 16562827 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 3.5 | ug/ml | 16562827 |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | > | 10 | ug/ml | 16562827 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 3.8 | ug/ml | 16562827 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC94236 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC37196 |
0.9921 | High Similarity | NPC161203 |
0.9762 | High Similarity | NPC229231 |
0.969 | High Similarity | NPC281521 |
0.969 | High Similarity | NPC255147 |
0.969 | High Similarity | NPC201357 |
0.9535 | High Similarity | NPC269528 |
0.9524 | High Similarity | NPC216836 |
0.9453 | High Similarity | NPC214860 |
0.938 | High Similarity | NPC82503 |
0.9375 | High Similarity | NPC45824 |
0.9318 | High Similarity | NPC476698 |
0.9297 | High Similarity | NPC266691 |
0.9242 | High Similarity | NPC134968 |
0.9242 | High Similarity | NPC472337 |
0.9237 | High Similarity | NPC36661 |
0.9225 | High Similarity | NPC10225 |
0.9225 | High Similarity | NPC58164 |
0.9219 | High Similarity | NPC236760 |
0.9206 | High Similarity | NPC95168 |
0.9173 | High Similarity | NPC472334 |
0.9173 | High Similarity | NPC472336 |
0.9154 | High Similarity | NPC51840 |
0.9154 | High Similarity | NPC234488 |
0.9154 | High Similarity | NPC220935 |
0.9154 | High Similarity | NPC311680 |
0.9154 | High Similarity | NPC299221 |
0.9147 | High Similarity | NPC63179 |
0.9104 | High Similarity | NPC102904 |
0.9104 | High Similarity | NPC326797 |
0.9104 | High Similarity | NPC103976 |
0.9104 | High Similarity | NPC107551 |
0.9104 | High Similarity | NPC474282 |
0.9104 | High Similarity | NPC276490 |
0.9104 | High Similarity | NPC176051 |
0.9098 | High Similarity | NPC261873 |
0.9098 | High Similarity | NPC283009 |
0.9091 | High Similarity | NPC229442 |
0.9091 | High Similarity | NPC168059 |
0.907 | High Similarity | NPC210355 |
0.907 | High Similarity | NPC50368 |
0.9062 | High Similarity | NPC299584 |
0.9062 | High Similarity | NPC265483 |
0.9062 | High Similarity | NPC82483 |
0.9051 | High Similarity | NPC477616 |
0.9048 | High Similarity | NPC75713 |
0.9037 | High Similarity | NPC25966 |
0.9037 | High Similarity | NPC127218 |
0.9037 | High Similarity | NPC245207 |
0.9037 | High Similarity | NPC319647 |
0.9023 | High Similarity | NPC106215 |
0.9023 | High Similarity | NPC103967 |
0.9023 | High Similarity | NPC310854 |
0.9015 | High Similarity | NPC127624 |
0.9015 | High Similarity | NPC86655 |
0.9015 | High Similarity | NPC6451 |
0.9015 | High Similarity | NPC202762 |
0.9008 | High Similarity | NPC474481 |
0.8992 | High Similarity | NPC476006 |
0.8992 | High Similarity | NPC103823 |
0.8992 | High Similarity | NPC112596 |
0.8992 | High Similarity | NPC44748 |
0.8992 | High Similarity | NPC78974 |
0.8992 | High Similarity | NPC28730 |
0.8992 | High Similarity | NPC223136 |
0.8992 | High Similarity | NPC214406 |
0.8992 | High Similarity | NPC18924 |
0.8984 | High Similarity | NPC183446 |
0.8971 | High Similarity | NPC160283 |
0.8971 | High Similarity | NPC254759 |
0.8963 | High Similarity | NPC73535 |
0.8963 | High Similarity | NPC272157 |
0.8963 | High Similarity | NPC25111 |
0.8963 | High Similarity | NPC90615 |
0.8963 | High Similarity | NPC201145 |
0.8963 | High Similarity | NPC6262 |
0.8955 | High Similarity | NPC474206 |
0.8955 | High Similarity | NPC121812 |
0.8955 | High Similarity | NPC94750 |
0.8955 | High Similarity | NPC112246 |
0.8955 | High Similarity | NPC470356 |
0.8955 | High Similarity | NPC112939 |
0.8955 | High Similarity | NPC195022 |
0.8947 | High Similarity | NPC475840 |
0.8939 | High Similarity | NPC472597 |
0.8939 | High Similarity | NPC45715 |
0.8939 | High Similarity | NPC232275 |
0.8939 | High Similarity | NPC474356 |
0.8939 | High Similarity | NPC12275 |
0.8923 | High Similarity | NPC124452 |
0.8923 | High Similarity | NPC324112 |
0.8923 | High Similarity | NPC159968 |
0.8923 | High Similarity | NPC282000 |
0.8923 | High Similarity | NPC236791 |
0.8923 | High Similarity | NPC74817 |
0.8923 | High Similarity | NPC169474 |
0.8923 | High Similarity | NPC293054 |
0.8923 | High Similarity | NPC82679 |
0.8923 | High Similarity | NPC246620 |
0.8915 | High Similarity | NPC234400 |
0.8915 | High Similarity | NPC60885 |
0.8906 | High Similarity | NPC121115 |
0.8905 | High Similarity | NPC471389 |
0.8897 | High Similarity | NPC292882 |
0.8897 | High Similarity | NPC19869 |
0.8889 | High Similarity | NPC114155 |
0.8889 | High Similarity | NPC306441 |
0.8889 | High Similarity | NPC227503 |
0.8889 | High Similarity | NPC248727 |
0.8889 | High Similarity | NPC270456 |
0.8889 | High Similarity | NPC300846 |
0.8889 | High Similarity | NPC173660 |
0.8889 | High Similarity | NPC16435 |
0.8889 | High Similarity | NPC162659 |
0.8889 | High Similarity | NPC265433 |
0.8889 | High Similarity | NPC476639 |
0.8889 | High Similarity | NPC230734 |
0.8889 | High Similarity | NPC474639 |
0.8881 | High Similarity | NPC317380 |
0.8872 | High Similarity | NPC7903 |
0.8872 | High Similarity | NPC218884 |
0.8872 | High Similarity | NPC35932 |
0.8872 | High Similarity | NPC184447 |
0.8872 | High Similarity | NPC16208 |
0.8872 | High Similarity | NPC160991 |
0.8864 | High Similarity | NPC472338 |
0.8864 | High Similarity | NPC224157 |
0.8864 | High Similarity | NPC91291 |
0.8864 | High Similarity | NPC192687 |
0.8855 | High Similarity | NPC19694 |
0.8846 | High Similarity | NPC245060 |
0.8841 | High Similarity | NPC107161 |
0.8841 | High Similarity | NPC472335 |
0.8841 | High Similarity | NPC472332 |
0.8837 | High Similarity | NPC228972 |
0.8837 | High Similarity | NPC122792 |
0.8832 | High Similarity | NPC73505 |
0.8832 | High Similarity | NPC295719 |
0.8832 | High Similarity | NPC34431 |
0.8832 | High Similarity | NPC165026 |
0.8832 | High Similarity | NPC259519 |
0.8828 | High Similarity | NPC246967 |
0.8828 | High Similarity | NPC135414 |
0.8828 | High Similarity | NPC474864 |
0.8828 | High Similarity | NPC262253 |
0.8828 | High Similarity | NPC473411 |
0.8828 | High Similarity | NPC71579 |
0.8824 | High Similarity | NPC211549 |
0.8815 | High Similarity | NPC260898 |
0.8815 | High Similarity | NPC234333 |
0.8815 | High Similarity | NPC111655 |
0.8815 | High Similarity | NPC61946 |
0.8815 | High Similarity | NPC47398 |
0.8815 | High Similarity | NPC252095 |
0.8815 | High Similarity | NPC151224 |
0.8806 | High Similarity | NPC11060 |
0.8806 | High Similarity | NPC474810 |
0.8794 | High Similarity | NPC178129 |
0.8788 | High Similarity | NPC190144 |
0.8788 | High Similarity | NPC190629 |
0.8788 | High Similarity | NPC210623 |
0.8788 | High Similarity | NPC218856 |
0.8788 | High Similarity | NPC470258 |
0.8788 | High Similarity | NPC273295 |
0.8788 | High Similarity | NPC226788 |
0.8788 | High Similarity | NPC222004 |
0.8788 | High Similarity | NPC202582 |
0.8788 | High Similarity | NPC285339 |
0.8788 | High Similarity | NPC3439 |
0.8779 | High Similarity | NPC470699 |
0.8769 | High Similarity | NPC193544 |
0.8769 | High Similarity | NPC203133 |
0.8769 | High Similarity | NPC17943 |
0.8769 | High Similarity | NPC251855 |
0.8769 | High Similarity | NPC472093 |
0.8769 | High Similarity | NPC298757 |
0.8769 | High Similarity | NPC233410 |
0.8769 | High Similarity | NPC116907 |
0.8769 | High Similarity | NPC117214 |
0.8769 | High Similarity | NPC208950 |
0.8769 | High Similarity | NPC475169 |
0.8769 | High Similarity | NPC221077 |
0.8769 | High Similarity | NPC57490 |
0.8769 | High Similarity | NPC105925 |
0.8768 | High Similarity | NPC247291 |
0.8768 | High Similarity | NPC311530 |
0.8759 | High Similarity | NPC70682 |
0.8759 | High Similarity | NPC212942 |
0.8759 | High Similarity | NPC260741 |
0.8759 | High Similarity | NPC29868 |
0.8759 | High Similarity | NPC471388 |
0.8759 | High Similarity | NPC79622 |
0.875 | High Similarity | NPC145780 |
0.875 | High Similarity | NPC269091 |
0.875 | High Similarity | NPC302701 |
0.8741 | High Similarity | NPC170694 |
0.8731 | High Similarity | NPC470752 |
0.8723 | High Similarity | NPC112251 |
0.8722 | High Similarity | NPC126836 |
0.8714 | High Similarity | NPC45257 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC94236 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8712 | High Similarity | NPD1529 | Clinical (unspecified phase) |
0.8647 | High Similarity | NPD3027 | Phase 3 |
0.8636 | High Similarity | NPD1530 | Clinical (unspecified phase) |
0.8593 | High Similarity | NPD1612 | Clinical (unspecified phase) |
0.8593 | High Similarity | NPD1613 | Approved |
0.8133 | Intermediate Similarity | NPD2801 | Approved |
0.8102 | Intermediate Similarity | NPD4625 | Phase 3 |
0.8088 | Intermediate Similarity | NPD3018 | Phase 2 |
0.806 | Intermediate Similarity | NPD4749 | Approved |
0.7926 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7926 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7919 | Intermediate Similarity | NPD1653 | Approved |
0.7899 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7879 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7852 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7829 | Intermediate Similarity | NPD1934 | Approved |
0.7786 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7786 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7786 | Intermediate Similarity | NPD6671 | Approved |
0.7778 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7752 | Intermediate Similarity | NPD228 | Approved |
0.7698 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7677 | Intermediate Similarity | NPD3882 | Suspended |
0.7664 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7662 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7651 | Intermediate Similarity | NPD1511 | Approved |
0.7647 | Intermediate Similarity | NPD1091 | Approved |
0.7638 | Intermediate Similarity | NPD968 | Approved |
0.7574 | Intermediate Similarity | NPD3496 | Discontinued |
0.7552 | Intermediate Similarity | NPD1558 | Phase 1 |
0.755 | Intermediate Similarity | NPD1512 | Approved |
0.75 | Intermediate Similarity | NPD5283 | Phase 1 |
0.75 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD3540 | Phase 1 |
0.7482 | Intermediate Similarity | NPD6696 | Suspended |
0.7468 | Intermediate Similarity | NPD4675 | Approved |
0.7468 | Intermediate Similarity | NPD4678 | Approved |
0.7453 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7453 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7453 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7452 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7442 | Intermediate Similarity | NPD290 | Approved |
0.7434 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7423 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7415 | Intermediate Similarity | NPD6100 | Approved |
0.7415 | Intermediate Similarity | NPD3539 | Phase 1 |
0.7415 | Intermediate Similarity | NPD6099 | Approved |
0.7413 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD422 | Phase 1 |
0.7389 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7383 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7358 | Intermediate Similarity | NPD6234 | Discontinued |
0.7328 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7317 | Intermediate Similarity | NPD7054 | Approved |
0.731 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7297 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7273 | Intermediate Similarity | NPD7472 | Approved |
0.7273 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7267 | Intermediate Similarity | NPD6674 | Discontinued |
0.7256 | Intermediate Similarity | NPD3818 | Discontinued |
0.7246 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7246 | Intermediate Similarity | NPD1778 | Approved |
0.7222 | Intermediate Similarity | NPD6232 | Discontinued |
0.7219 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7197 | Intermediate Similarity | NPD3022 | Approved |
0.7197 | Intermediate Similarity | NPD3021 | Approved |
0.719 | Intermediate Similarity | NPD4357 | Discontinued |
0.7171 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.717 | Intermediate Similarity | NPD5402 | Approved |
0.716 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7153 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7152 | Intermediate Similarity | NPD37 | Approved |
0.7143 | Intermediate Similarity | NPD447 | Suspended |
0.7143 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD3705 | Approved |
0.7143 | Intermediate Similarity | NPD1611 | Approved |
0.7143 | Intermediate Similarity | NPD4123 | Phase 3 |
0.7126 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7125 | Intermediate Similarity | NPD4965 | Approved |
0.7125 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7125 | Intermediate Similarity | NPD4966 | Approved |
0.7121 | Intermediate Similarity | NPD2684 | Approved |
0.7113 | Intermediate Similarity | NPD2922 | Phase 1 |
0.7111 | Intermediate Similarity | NPD1398 | Phase 1 |
0.7109 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7107 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7105 | Intermediate Similarity | NPD3892 | Phase 2 |
0.7099 | Intermediate Similarity | NPD5494 | Approved |
0.7091 | Intermediate Similarity | NPD7473 | Discontinued |
0.7083 | Intermediate Similarity | NPD7251 | Discontinued |
0.708 | Intermediate Similarity | NPD7340 | Approved |
0.7075 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7075 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7073 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD2219 | Phase 1 |
0.7059 | Intermediate Similarity | NPD2677 | Approved |
0.7054 | Intermediate Similarity | NPD291 | Approved |
0.7048 | Intermediate Similarity | NPD7228 | Approved |
0.7042 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7041 | Intermediate Similarity | NPD7549 | Discontinued |
0.7041 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7039 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7039 | Intermediate Similarity | NPD5177 | Phase 3 |
0.7037 | Intermediate Similarity | NPD7843 | Approved |
0.7032 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7027 | Intermediate Similarity | NPD230 | Phase 1 |
0.7024 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.702 | Intermediate Similarity | NPD5762 | Approved |
0.702 | Intermediate Similarity | NPD7266 | Discontinued |
0.702 | Intermediate Similarity | NPD5763 | Approved |
0.7007 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7007 | Intermediate Similarity | NPD7157 | Approved |
0.6993 | Remote Similarity | NPD8651 | Approved |
0.6993 | Remote Similarity | NPD3225 | Approved |
0.6987 | Remote Similarity | NPD5261 | Clinical (unspecified phase) |
0.6984 | Remote Similarity | NPD9296 | Approved |
0.698 | Remote Similarity | NPD1607 | Approved |
0.6975 | Remote Similarity | NPD7975 | Clinical (unspecified phase) |
0.6968 | Remote Similarity | NPD7212 | Phase 2 |
0.6968 | Remote Similarity | NPD1774 | Approved |
0.6968 | Remote Similarity | NPD7213 | Phase 3 |
0.6968 | Remote Similarity | NPD6799 | Approved |
0.6962 | Remote Similarity | NPD6055 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD8053 | Approved |
0.6959 | Remote Similarity | NPD8054 | Approved |
0.6957 | Remote Similarity | NPD6374 | Clinical (unspecified phase) |
0.6954 | Remote Similarity | NPD2935 | Discontinued |
0.6948 | Remote Similarity | NPD6190 | Approved |
0.6933 | Remote Similarity | NPD4536 | Approved |
0.6933 | Remote Similarity | NPD4537 | Clinical (unspecified phase) |
0.6933 | Remote Similarity | NPD4538 | Approved |
0.6929 | Remote Similarity | NPD1357 | Approved |
0.6928 | Remote Similarity | NPD3060 | Approved |
0.6923 | Remote Similarity | NPD940 | Approved |
0.6923 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD846 | Approved |
0.6918 | Remote Similarity | NPD5752 | Clinical (unspecified phase) |
0.6918 | Remote Similarity | NPD4380 | Phase 2 |
0.6918 | Remote Similarity | NPD6599 | Discontinued |
0.6912 | Remote Similarity | NPD7635 | Approved |
0.6908 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.6908 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.6908 | Remote Similarity | NPD2029 | Clinical (unspecified phase) |
0.6903 | Remote Similarity | NPD7124 | Phase 2 |
0.6897 | Remote Similarity | NPD6584 | Phase 3 |
0.6892 | Remote Similarity | NPD2674 | Phase 3 |
0.6883 | Remote Similarity | NPD4628 | Phase 3 |
0.6883 | Remote Similarity | NPD3750 | Approved |
0.6882 | Remote Similarity | NPD6559 | Discontinued |
0.6871 | Remote Similarity | NPD7095 | Approved |
0.6871 | Remote Similarity | NPD4381 | Clinical (unspecified phase) |
0.6871 | Remote Similarity | NPD4055 | Discovery |
0.6871 | Remote Similarity | NPD7075 | Discontinued |
0.6863 | Remote Similarity | NPD1549 | Phase 2 |
0.6859 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6855 | Remote Similarity | NPD4005 | Discontinued |
0.6853 | Remote Similarity | NPD2231 | Phase 2 |
0.6853 | Remote Similarity | NPD2235 | Phase 2 |
0.6853 | Remote Similarity | NPD1608 | Approved |
0.6846 | Remote Similarity | NPD1240 | Approved |
0.6842 | Remote Similarity | NPD6032 | Approved |
0.6835 | Remote Similarity | NPD5403 | Approved |
0.6828 | Remote Similarity | NPD2797 | Approved |
0.6824 | Remote Similarity | NPD3144 | Approved |
0.6824 | Remote Similarity | NPD5111 | Phase 2 |
0.6824 | Remote Similarity | NPD5109 | Approved |
0.6824 | Remote Similarity | NPD5110 | Phase 2 |
0.6824 | Remote Similarity | NPD3145 | Approved |
0.6824 | Remote Similarity | NPD6798 | Discontinued |
0.6818 | Remote Similarity | NPD4237 | Approved |
0.6818 | Remote Similarity | NPD4236 | Phase 3 |
0.6818 | Remote Similarity | NPD4162 | Approved |
0.6815 | Remote Similarity | NPD1754 | Clinical (unspecified phase) |
0.6809 | Remote Similarity | NPD5585 | Approved |
0.6807 | Remote Similarity | NPD3787 | Discontinued |
0.68 | Remote Similarity | NPD5124 | Phase 1 |
0.68 | Remote Similarity | NPD1933 | Approved |
0.68 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD6355 | Discontinued |
0.6797 | Remote Similarity | NPD1375 | Discontinued |
0.6797 | Remote Similarity | NPD844 | Approved |
0.679 | Remote Similarity | NPD5929 | Approved |
0.679 | Remote Similarity | NPD7096 | Clinical (unspecified phase) |
0.6788 | Remote Similarity | NPD5677 | Discontinued |
0.6786 | Remote Similarity | NPD1408 | Clinical (unspecified phase) |
0.6783 | Remote Similarity | NPD1535 | Discovery |
0.6776 | Remote Similarity | NPD7033 | Discontinued |
0.6776 | Remote Similarity | NPD6029 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD5588 | Approved |
0.6776 | Remote Similarity | NPD6028 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD1510 | Phase 2 |
0.6776 | Remote Similarity | NPD5960 | Phase 3 |
0.6774 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6774 | Remote Similarity | NPD4110 | Phase 3 |
0.6774 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6772 | Remote Similarity | NPD6090 | Discontinued |
0.6761 | Remote Similarity | NPD6516 | Phase 2 |
0.6761 | Remote Similarity | NPD5846 | Approved |
0.6761 | Remote Similarity | NPD4626 | Approved |
0.6755 | Remote Similarity | NPD6653 | Approved |
PubChem CID   | 11609116 |
ChEMBL   | CHEMBL482245 |
ZINC   |
Molecular Weight:   | 300.10 |
ALogP:   | -0.0685 |
MLogP:   | 2.78 |
XLogP:   | 2.082 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 68.15 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 22 |